Medtronic plc Quarterly Accumulated Other Comprehensive Income (Loss), Net of Tax in USD from Q1 2012 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.
Summary
Medtronic plc quarterly Accumulated Other Comprehensive Income (Loss), Net of Tax history and growth rate from Q1 2012 to Q2 2024.
  • Medtronic plc Accumulated Other Comprehensive Income (Loss), Net of Tax for the quarter ending July 26, 2024 was -$3.41B, a 7.19% increase year-over-year.
Accumulated Other Comprehensive Income (Loss), Net of Tax, Quarterly (USD)
Accumulated Other Comprehensive Income (Loss), Net of Tax, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 -$3.41B +$264M +7.19% Jul 26, 2024 10-Q 2024-08-27
Q1 2024 -$3.32B +$181M +5.17% Apr 26, 2024 10-Q 2024-08-27
Q4 2023 -$3.46B -$270M -8.47% Jan 26, 2024 10-Q 2024-02-27
Q3 2023 -$3.38B -$1.02B -43% Oct 27, 2023 10-Q 2023-11-30
Q2 2023 -$3.67B -$1.74B -89.5% Jul 28, 2023 10-Q 2023-08-31
Q1 2023 -$3.5B -$1.23B -54.5% Apr 28, 2023 10-K 2024-06-20
Q4 2022 -$3.19B -$310M -10.8% Jan 27, 2023 10-Q 2023-03-01
Q3 2022 -$2.36B +$681M +22.4% Oct 28, 2022 10-Q 2022-12-01
Q2 2022 -$1.94B +$1.27B +39.6% Jul 29, 2022 10-Q 2022-09-01
Q1 2022 -$2.27B +$1.22B +35% Apr 29, 2022 10-K 2023-06-22
Q4 2021 -$2.88B +$1.04B +26.6% Jan 28, 2022 10-Q 2022-03-03
Q3 2021 -$3.04B +$801M +20.8% Oct 29, 2021 10-Q 2021-12-02
Q2 2021 -$3.21B +$573M +15.2% Jul 30, 2021 10-Q 2021-09-02
Q1 2021 -$3.49B +$75M +2.11% Apr 30, 2021 10-K 2022-06-23
Q4 2020 -$3.92B -$1.38B -54% Jan 29, 2021 10-Q 2021-03-05
Q3 2020 -$3.84B -$1.23B -47.2% Oct 30, 2020 10-Q 2020-12-03
Q2 2020 -$3.78B -$1.3B -52.3% Jul 31, 2020 10-Q 2020-09-03
Q1 2020 -$3.56B -$849M -31.3% Apr 24, 2020 10-K 2021-06-25
Q4 2019 -$2.55B -$88M -3.58% Jan 24, 2020 10-Q 2020-02-28
Q3 2019 -$2.61B +$1M +0.04% Oct 25, 2019 10-Q 2019-12-03
Q2 2019 -$2.48B -$161M -6.93% Jul 26, 2019 10-Q 2019-08-30
Q1 2019 -$2.71B -$925M -51.8% Apr 26, 2019 10-K 2020-06-19
Q4 2018 -$2.46B -$1.08B -77.9% Jan 25, 2019 10-Q 2019-03-01
Q3 2018 -$2.61B -$552M -26.8% Oct 26, 2018 10-Q 2018-11-29
Q2 2018 -$2.32B -$399M -20.7% Jul 27, 2018 10-Q 2018-08-31
Q1 2018 -$1.79B +$827M +31.6% Apr 27, 2018 10-K 2019-06-21
Q4 2017 -$1.38B +$1.5B +52% Jan 26, 2018 10-Q 2018-03-02
Q3 2017 -$2.06B +$268M +11.5% Oct 27, 2017 10-Q 2017-12-04
Q2 2017 -$1.92B +$100M +4.94% Jul 28, 2017 10-Q 2017-09-01
Q1 2017 -$2.61B -$745M -39.9% Apr 28, 2017 10-K 2018-06-22
Q4 2016 -$2.88B +$86M +2.9% Jan 27, 2017 10-Q 2017-03-03
Q3 2016 -$2.33B -$857M -58.3% Oct 28, 2016 10-Q 2016-12-05
Q2 2016 -$2.02B -$668M -49.3% Jul 29, 2016 10-Q 2016-09-07
Q1 2016 -$1.87B -$684M -57.8% Apr 29, 2016 10-K 2017-06-27
Q4 2015 -$2.97B -$2.3B -349% Jan 29, 2016 10-Q 2016-03-09
Q3 2015 -$1.47B -$965M -191% Oct 30, 2015 10-Q 2015-12-09
Q2 2015 -$1.36B -$868M -178% Jul 31, 2015 10-Q 2015-09-09
Q1 2015 -$1.18B -$587M -98.3% Apr 24, 2015 10-K 2016-06-28
Q4 2014 -$661M Jan 23, 2015 10-Q 2016-03-09
Q3 2014 -$506M Oct 24, 2014 10-Q 2015-12-09
Q2 2014 -$488M Jul 25, 2014 10-Q 2015-09-09
Q1 2014 -$597M -$105M -21.3% Apr 25, 2014 10-Q 2016-03-09
Q1 2013 -$492M -$19M -4.02% Apr 26, 2013 10-K 2015-06-23
Q1 2012 -$473M Apr 27, 2012 10-K 2015-06-23
* An asterisk sign (*) next to the value indicates that the value is likely invalid.